昊海生物科技(06826)：7月未实施A股股份回购

Core Viewpoint - Haohai Biological Technology (06826) announced that as of July 31, 2025, the company has not implemented an A-share buyback program, having repurchased a total of 1.8324 million A-shares, representing 0.79% of the total share capital of 233 million shares [1] Summary by Category - Share Buyback Details - The company repurchased 1.8324 million A-shares through centralized bidding [1] - This represents 0.79% of the total share capital of 233 million shares [1] - The highest transaction price was 63.58 yuan per share, while the lowest was 49.25 yuan per share [1] - The total amount spent on the buyback was 104 million yuan, excluding transaction fees [1]